ArticleJournal of clinical medicine2024

Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease.

Lucia Gozzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.